Skip to search.
 All Ordinaries Down 0.80%

Neostem, Inc. (NBS)

-NasdaqCM
2.67 Up 0.01(0.38%) 01:57 - Nasdaq Real-Time Price
Add to Portfolio
Prev Close:2.66
Open:2.69
Bid:2.71 x 200
Ask:2.73 x 1900
1y Target Est:13.50
Beta:0.55
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:2.64 - 2.84
52wk Range:2.15 - 7.23
Volume:383,975
Avg Vol (3m):566,767
Market Cap:107.20M
P/E (ttm):N/A
EPS (ttm):-1.72
Div & Yield:0.06 (1.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NBSUp 0.38%107.20M
BAXDown 0.28%36.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.36
Quarterly EPS Est (Jun-15) :-0.33
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback